CTKB
Cytek BioSciences Inc

316
Mkt Cap
$575.9M
Volume
1.4M
52W High
$6.18
52W Low
$2.37
PE Ratio
-44.31
CTKB Fundamentals
Price
$4.48
Prev Close
$4.40
Open
$4.24
50D MA
$4.94
Beta
1.36
Avg. Volume
830,031.10
EPS (Annual)
-$0.5209
P/B
1.51
Rev/Employee
$287,847.14
$416.61
Loading...
Loading...
News
all
press releases
Cytek Biosciences (NASDAQ:CTKB) Announces Quarterly Earnings Results, Misses Estimates By $0.36 EPS
Cytek Biosciences (NASDAQ:CTKB - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Cytek Biosciences Q4 Earnings Call Highlights
Cytek Biosciences (NASDAQ:CTKB) reported fourth-quarter and full-year 2025 results on Wednesday, describing a return to growth in the back half of the year amid what management characterized as a...
MarketBeat·3d ago
News Placeholder
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -166.67% and +0.23%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Earnings Breakdown: Cytek Biosciences Q4
read more...
Benzinga·3d ago
News Placeholder
Cytek Biosciences (CTKB) Expected to Announce Earnings on Thursday
Cytek Biosciences (NASDAQ:CTKB) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...
MarketBeat·11d ago
News Placeholder
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Analysts
Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) has been given a consensus recommendation of "Hold" by the seven research firms that are covering the company, MarketBeat Ratings reports. Two...
MarketBeat·25d ago
News Placeholder
Brown Capital Management LLC Has $17.20 Million Position in Cytek Biosciences, Inc. $CTKB
Brown Capital Management LLC trimmed its position in Cytek Biosciences, Inc. (NASDAQ:CTKB - Free Report) by 30.3% during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·27d ago
News Placeholder
Cytek Biosciences (NASDAQ:CTKB) Shares Up 8.2% - Here's What Happened
Cytek Biosciences (NASDAQ:CTKB) Shares Up 8.2% - Here's Why...
MarketBeat·2mo ago
News Placeholder
Cytek Biosciences Preliminary Q4 Revenue Up 8%
(RTTNews) - Cytek Biosciences (CTKB) announced preliminary revenue results for the fourth quarter and full year ended December 31, 2025. Cytek expects total revenue for the full year 2025 to be...
Nasdaq News: Markets·2mo ago
News Placeholder
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of "Hold" from Analysts
Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) has received a consensus recommendation of "Hold" from the eight research firms that are currently covering the firm, Marketbeat reports. Two...
MarketBeat·2mo ago
<
1
2
...
>

Latest CTKB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.